1. Peshkin BS, DeMarco TA, Brogan BM, et al. BRCA 1/2 testing: Complex themes in result interpretation. J Clin Oncol 2001;19:2555–2565.
2. Nixon DW. Status of cancer prevention clinical trials. In: DeVita VT Jr, Hell-man S, Rosenberg SA, eds. Cancer Prevention Update. Philadelphia: JB Lippincott; 1991:1–9.
3. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with HNPCC. Gastroenterology 1995;108:1405–1411.
4. Ang P, Garber JE. Genetic susceptibility for breast cancer—risk assessment and counseling. Semin Oncol 2001;28:419–433.
5. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI 1998;90:1371–1388.